NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody

(2014) A. M. Hernandez et al.   JOURNAL OF IMMUNOLOGY

Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: Results of a phase Ib/IIa study

(2010) Marta Osorio et al.   CANCER BIOLOGY & THERAPY

The Landmark Approval of Provenge®, What It Means to Immunology and “In This Issue”: The Complex Relation Between Vaccines and Autoimmunity

(2010) Adrian Bot   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Uniquely human evolution of sialic acid genetics and biology

(2010) A. Varki   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer

(2009) Hester van Cruijsen et al.   BMC CANCER

Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model

(2009) D. Fuentes et al.   BREAST CANCER RESEARCH AND TREATMENT

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Therapeutic vaccines in solid tumours: Can they be harmful?

(2009) Alexander M.M. Eggermont   EUROPEAN JOURNAL OF CANCER

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

(2009) Mayrel Labrada et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Prioritization of cancer antigens: keeping the target in sight

(2009) Joshua M Lang et al.   Expert Review of Vaccines

Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer

(2009) Douglas G. McNeel et al.   JOURNAL OF CLINICAL ONCOLOGY

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

(2009) Mariano R Gabri et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Crystal structure of an anti-ganglioside antibody, and modelling of the functional mimicry of its NeuGc-GM3 antigen by an anti-idiotypic antibody

(2009) Ariel Talavera et al.   MOLECULAR IMMUNOLOGY

Detection and Characterization of N-Glycolyated Gangliosides in Wilms Tumor by Immunohistochemistry

(2009) Alejandra M. Scursoni et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY

Relationship between risk information on total colonoscopy and patient preferences for colorectal cancer screening options: Analysis using the Analytic Hierarchy Process

(2008) Yuichi Katsumura et al.   BMC HEALTH SERVICES RESEARCH

Risk communication formats for low probability events: an exploratory study of patient preferences

(2008) James G Dolan et al.   BMC Medical Informatics and Decision Making

Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma

(2008) Y. Diaz et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function

(2008) J. de Leon et al.   INTERNATIONAL IMMUNOLOGY

Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression

(2008) M. Hedlund et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antibodies against gangliosides and ganglioside complexes in Guillain–Barré syndrome: New aspects of research

(2007) Susumu Kusunoki et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS